Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

23-07-2022 | Angiography | Retinal Disorders

Vitrectomy with ILM peeling in diabetic macular edema in one eye vs. intravitreal anti-VEGF injections in the second eye: a comparative study

Authors: Zofia Anna Nawrocka, Zofia Nawrocka, Jerzy Nawrocki

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 1/2023

Abstract

Purpose

The aim of this study was to compare the results of vitrectomy performed in patients’ worse eyes with diabetic macular edema to the results of continuous anti-VEGF treatment performed in patients’ fellow eyes.

Methods

A retrospective interventional study of 14 patients with diabetic macular edema in both eyes. The better eye was always qualified for aflibercept injections (group 1), and the worse eye was scheduled for vitrectomy (group 2). The follow-up lasted 12 months. The following parameters were measured: visual acuity (V), central retinal thickness (CRT), maximum retinal thickness (MRT), central choroidal thickness (CCT), superficial fovea avascular zone (sFAZ) and deep fovea avascular zone (dFAZ), and vessel density at the level of superficial (sVD) and deep (dVD) retinal vessels.

Results

None of the analyzed factors differed between groups with statistical significance at any timepoint. The time of recovery of vision was identical in both eyes (F = 0.91, p = 0.449). The final sFAZ was significantly smaller for group 2 (median 196 μm) than for group 1 (median 375 μm; U = 101.0; p = 0.022; r = 0.44).

Conclusion

Both techniques resulted in similar improvements in visual acuity and decreases in CRT after 1 year. sFAZ decreased in all eyes, with a higher extent after vitrectomy.

Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE (2008) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 115:1859–1868. https://doi.org/10.1016/j.ophtha.2008.08.023CrossRef

Diabetic Retinopathy Clinical Research Network Writing Committee, Bressler SB, Edwards AR, Chalam KV, Bressler NM, Glassman AR, Jaffe GJ (2014) Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology 132:1113–1122. https://doi.org/10.1016/j.ophtha.2009.10.040CrossRef

Michalewska Z, Stewart MW, Landers MB 3rd, Bednarski M, Adelman RA, Nawrocki J (2018) Vitrectomy in the management of diabetic macular edema in treatment naïve patients. Can J Ophthalmol 53(4):402–407. https://doi.org/10.1016/j.jcjo.2017.10.011CrossRef

Ichiyama Y, Sawada O, Mori T, Fujikawa M, Kawamura H, Ohji M (2016) The effectiveness of vitrectomy for diffuse diabetic macular edema may depend on its preoperative optical coherence tomography pattern. Graefes Arch Clin Exp Ophthalmol 254:1545–1551. https://doi.org/10.1007/s00417-015-3251-4CrossRef

Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL 3rd, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117:1064e1077.e35. https://doi.org/10.1001/jamaophthalmol.2018.3255CrossRef

Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW, Diabetic Retinopathy Clinical Research Network (2015) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 26(372):1193–203. https://doi.org/10.1056/NEJMoa1414264CrossRef

Gonzalez VH, Campbell J, Holekamp NM, Kiss S, Loewenstein A, Augustin AJ, Ma J, Ho AC, Patel V, Whitcup SM, Dugel PU (2016) Early and long-term responses to anti-vascular endothelial growth factor therapy in diabetic macular edema: analysis of protocol I data. Am J Ophthalmol 172:72e79. https://doi.org/10.1016/j.ajo.2016.09.012CrossRef

Cai S, Bressler NM (2017) Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T. Curr Opin Ophthalmol 28:636–643. https://doi.org/10.1097/ICU.0000000000000424CrossRef

Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122:258–260. https://doi.org/10.1016/s0002-9394(14)72018-5CrossRef

10.

Yanyali A, Bozkurt KT, Macin A, Horozoglu F, Nohutcu AF (2011) Quantitative assessment of photoreceptor layer in eyes with resolved edema after pars plana vitrectomy with internal limiting membrane removal for diabetic macularedema. Ophthalmologica 226:57–63. https://doi.org/10.1159/000327597CrossRef

11.

Morizane Y, Kimura S, Hosokawa M, Shiode Y, Hirano M, Doi S, Hosogi M, Fujiwara A, Inoue Y, Shiraga F (2015) Planned foveal detachment technique for the resolution of diffuse diabetic macular edema. Jpn J Ophthalmol 59:279–87. https://doi.org/10.1007/s10384-015-0390-4CrossRef

12.

Nawrocka ZA, Nawrocka Z, Nawrocki J (2022) Vitrectomy in diabetic macular edema - a swept-source optical coherence tomography (OCT) angiography study. Article in press, Ophthlmology Science

13.

Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, Baker CW, Berger BB, Bressler NM, Browning D, Elman MJ, Ferris FL 3rd, Friedman SM, Marcus DM, Melia M, Stockdale CR, Sun JK, Beck RW (2015) Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA 24(314):2137–2146. https://doi.org/10.1001/jama.2015.15217CrossRef

14.

Maturi RK, Glassman AR, Liu D, Beck RW, Bhavsar AR, Bressler NM, Jampol LM, Melia M, Punjabi OS, Salehi-Had H, Sun JK, for the Diabetic Retinopathy Clinical Research Network (2018) Effect of adding dexamethasone to continued ranibizumab treatment in patients with persistent diabetic macular edema: a DRCR Network phase 2 randomized clinical trial. JAMA Ophthalmol 1(136):29–38. https://doi.org/10.1001/jamaophthalmol.2017.4914CrossRef

15.

Hutton DW, Glassman AR, Stein JD, Bressler NM, Sun JK, DRCR Retina Network (2021) Costs of managing diabetic macular edema with good visual acuity with aflibercept, laser, or observation: DRCR Retina Network Protocol V. Am J Ophthalmol 230:297–302. https://doi.org/10.1016/j.ajo.2021.02.033CrossRef

16.

Laidlaw DA (2008) Vitrectomy for diabetic macular oedema. Eye 22:1337–1341. https://doi.org/10.1038/eye.2008.84CrossRef

17.

Lent-Schochet D, Lo T, Luu KY, Tran S, Wilson MD, Moshiri A, Park SS, Yiu G (2021) Natural history and predictors of vision loss in eyes with diabetic macular edema and good initial visual acuity. Retina 1(41):2132–2139. https://doi.org/10.1097/IAE.0000000000003167CrossRef

18.

Nasrallah FP, Jalkh AE, Van Coppenolle F, Kado M, Trempe CL, McMeel JW, Schepens CL (1988) The role of the vitreous in diabetic macular edema. Ophthalmology 95:1335–1339. https://doi.org/10.1016/S0161-6420(88)33004-6CrossRef

19.

Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M, Yoshida A (1997) Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 104:473–478. https://doi.org/10.1016/S0161-6420(97)30289-9CrossRef

20.

Stefansson E (2006) Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol 51:364–380. https://doi.org/10.1016/j.survophthal.2006.04.005CrossRef

21.

Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier B (2005) Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140:295–301. https://doi.org/10.1016/j.ajo.2005.03.045CrossRef

22.

Simunovic MP, Hunyor AP, Ho IV (2014) Vitrectomy for diabetic macular edema: a systematic review and meta-analysis. Can J Ophthalmol 49:188–195. https://doi.org/10.1016/j.jcjo.2013.11.012CrossRef

23.

Jackson TL, Nicod E, Angelis A, Grimaccia F, Pringle E, Kanavos P (2017) Pars plana vitrectomy for diabetic macular edema: a systematic review, meta-analysis, and synthesis of safety literature. Retina 37:886–895. https://doi.org/10.1097/IAE.0000000000001280CrossRef

24.

Modarres M (2016) Vitrectomy for diabetic macular edema; where are we? J Curr Ophthalmol 28(28):161–162. https://doi.org/10.1016/j.joco.2016.09.007CrossRef

25.

Waisbourd M, Goldstein M, Loewenstein A (2011) Treatment of diabetic retinopathy with anti-VEGF drugs. Acta Ophthalmol 89:203–207. https://doi.org/10.1016/j.joco.2016.09.007CrossRef

26.

Vaziri K, Schwartz SG, Relhan N, Kishor KS, Flynn HW Jr (2015) New therapeutic approaches in diabetic retinopathy. Rev Diabet Stud 12:196–210. https://doi.org/10.1900/RDS.2015.12.196CrossRef

27.

Freiberg FJ, Pfau M, Wons J, Wirth MA, Becker MD, Michels S (2016) Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 254:1051–1058. https://doi.org/10.1007/s00417-015-3148-2CrossRef

28.

Gill A, Cole ED, Novais EA, Louzada RN, de Carlo T, Duker JS, Waheed NK, Baumal CR, Witkin AJ (2017) Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography. Int J Retina Vitreous 19(3):19. https://doi.org/10.1186/s40942-017-0074-yCrossRef

Title: Vitrectomy with ILM peeling in diabetic macular edema in one eye vs. intravitreal anti-VEGF injections in the second eye: a comparative study
Authors: Zofia Anna Nawrocka
Zofia Nawrocka
Jerzy Nawrocki
Publication date: 23-07-2022
Publisher: Springer Berlin Heidelberg
Keywords: Angiography
Edema
Vitrectomy
Peeling
Aflibercept
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 1/2023
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-022-05774-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Vitrectomy with ILM peeling in diabetic macular edema in one eye vs. intravitreal anti-VEGF injections in the second eye: a comparative study

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Clinical results of topography-guided laser-assisted in situ keratomileusis using the anterior corneal astigmatism axis and manifest refractive astigmatism axis

Serum Ang-1/Ang-2 ratio may be a promising biomarker for evaluating severity of diabetic retinopathy

Development of posttraumatic stress disorder and depression after open globe injury in adults

Systemic and ocular associations in pediatric patients undergoing cataract surgery

Use of optical coherence tomography angiography in the uveitis clinic

Legal obligation in the general population: face mask influence on endophthalmitis after intravitreal injection